Subcutaneous Injection of Bacterial Antigen to Induce Systemic Inflammation in a Murine Model
JoVE Encyclopedia of Experiments
Immunology
0 views • 3:52 min • July 8th, 2025
Loading...
Overview
This article demonstrates the induction of systemic inflammation in mice using a mycobacterial antigen-adjuvant emulsion, serving as a model for post-infectious uveitis. The protocol details the preparation of the antigen emulsion, subcutaneous injection near lymph nodes, and the resulting immune activation leading to widespread inflammation. This model enables researchers to study immune mechanisms underlying post-infectious uveitis.
Key Study Components
Area of Science
- Immunology
- Ophthalmology
- Animal models of inflammation
Background
- Post-infectious uveitis is an inflammatory eye disease that can follow systemic infections.
- Animal models are essential for studying the immune mechanisms involved in uveitis.
- Mycobacterial antigens are commonly used to induce immune responses in experimental models.
- Systemic inflammation can be triggered by subcutaneous injection of antigen-adjuvant emulsions.
Purpose of Study
- To establish a reproducible mouse model for post-infectious uveitis using mycobacterial antigens.
- To demonstrate the protocol for inducing systemic inflammation via subcutaneous injection.
- To facilitate the study of immune cell activation and cytokine release in vivo.
Methods Used
- Preparation of a fine suspension of Mycobacterium tuberculosis H37Ra in PBS using sonication on ice.
- Emulsification of the mycobacterial suspension with Freund's incomplete adjuvant to achieve a toothpaste-like consistency.
- Subcutaneous injection of 50 microliters of the emulsion near the inguinal lymph nodes of anesthetized C57Black/6J mice.
- Monitoring of immune activation, including antigen presentation, T cell activation, and cytokine release.
Main Results
- Successful induction of localized and systemic inflammation in mice.
- Activation of antigen-presenting cells and helper T cells in lymph nodes.
- Release of pro-inflammatory cytokines and recruitment of immune cells to various tissues.
- Establishment of a model suitable for studying post-infectious uveitis mechanisms.
Conclusions
- The described protocol reliably induces systemic inflammation in mice using mycobacterial antigen-adjuvant depots.
- This model is valuable for investigating immune responses relevant to post-infectious uveitis.
- It provides a platform for testing therapeutic interventions targeting inflammatory pathways.
Frequently Asked Questions
What is the purpose of using a mycobacterial antigen-adjuvant emulsion in this model?
The emulsion triggers a robust immune response, leading to systemic inflammation that models post-infectious uveitis.
Why is sonication performed on ice during emulsion preparation?
Sonication on ice prevents overheating, ensuring the mycobacterial suspension remains stable and evenly dispersed.
Where is the emulsion injected in the mouse?
The emulsion is injected subcutaneously near the inguinal lymph nodes, either on the dorsal hips or ventral legs.
How does the injection lead to systemic inflammation?
Antigen-presenting cells process the injected antigens, activate T cells in lymph nodes, and release cytokines that spread inflammation throughout the body.
What mouse strain is used in this protocol?
C57Black/6J mice aged 6 to 10 weeks are used for the injections.
What are the key signs of successful induction of inflammation?
Activation of immune cells, cytokine release, and recruitment of inflammatory cells to various tissues indicate successful induction.
Can this model be used to test anti-inflammatory therapies?
Yes, the model provides a platform for evaluating interventions targeting immune and inflammatory pathways relevant to uveitis.
Executive Industry Relevance
Inducing systemic inflammation in murine models via subcutaneous injection of mycobacterial antigen-adjuvant depots enables controlled interrogation of immune activation pathways relevant to post-infectious inflammatory diseases. This approach provides a reproducible platform for evaluating immune cell recruitment, cytokine release, and systemic inflammatory responses, supporting early-stage target validation and mechanistic de-risking in immunology-focused drug discovery. The model's translational relevance to post-infectious uveitis enhances its value for portfolio triage and preclinical candidate assessment.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of immune activation mechanisms and cytokine signaling cascades.
- Supports functional validation of inflammatory pathway targets in vivo.
- Facilitates mechanistic de-risking by modeling systemic immune responses.
- Provides a platform for hypothesis-driven evaluation of immune modulators.
Screening & Assay Development
- Establishes a validated in vivo system for quantifying cytokine and immune cell responses.
- Supports reproducible induction of inflammation for comparative compound screening.
- Enables standardization of immune readouts for downstream assay development.
- Prepares a robust model for evaluating anti-inflammatory candidate efficacy.
Translational & Preclinical Research
- Aligns with disease-relevant mechanisms underlying post-infectious uveitis.
- Provides continuity from discovery-stage immune activation to preclinical validation of therapeutic interventions.
- Enables risk-adjusted advancement decisions based on in vivo immune modulation.
- Supports biomarker identification for translational research in inflammatory diseases.
Pipeline & Workflow Integration
This murine inflammation model integrates into the discovery-to-preclinical continuum, bridging early immune pathway validation with translational candidate assessment.
- Discovery Biology: Facilitates hypothesis testing of immune activation and cytokine release mechanisms.
- Screening: Provides a reproducible in vivo platform for quantitative immune response measurement.
- Analytics: Enables collection of cytokine, immune cell, and tissue inflammation readouts for comparative analysis.
- Translational Research: Connects mechanistic findings to disease-relevant preclinical endpoints in uveitis and systemic inflammation.
- Enterprise Reuse: Offers a standardized, reusable model for immune modulation studies across therapeutic programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in immune target validation and pathway de-risking.
- Operational Value: Delivers standardized, scalable, and reproducible in vivo inflammation induction.
- Strategic Value: Improves go/no-go decisions for immunology portfolios by providing robust mechanistic data.
- Portfolio Impact: Enables risk-adjusted prioritization of immune-modulating candidates for advancement.
Implementation Considerations
- Requires expertise in murine handling, subcutaneous injection, and immune assay interpretation.
- Needs access to sonication equipment and validated antigen-adjuvant preparation protocols.
- Demands cross-team standardization of injection sites and immune readout collection.
- Adaptation may be needed for different mouse strains or antigen systems.
- Limitations include model specificity to post-infectious inflammation and requirement for precise dosing.
Biopharma FAQs
Why does null hypothesis testing matter for mycobacterial antigen-induced inflammation?
Null hypothesis testing enables objective evaluation of whether observed immune activation and cytokine release are specifically attributable to the antigen-adjuvant injection, supporting rigorous target validation and mechanistic clarity in early discovery.
How does independent variable isolation fit the subcutaneous injection workflow?
Isolating the injected antigen-adjuvant as the independent variable ensures that downstream immune responses and systemic inflammation can be directly linked to the intervention, strengthening the interpretability of mechanistic studies and screening outputs.
What do quantitative cytokine measurements enable in this murine model?
Quantitative measurement of cytokines provides actionable data on the magnitude and kinetics of systemic inflammation, enabling comparative assessment of immune modulators and supporting data-driven advancement decisions in immunology pipelines.
Why are replication requirements critical for cross-functional inflammation studies?
Replication ensures that immune activation and inflammatory readouts are consistent and reproducible across experiments and teams, facilitating reliable cross-functional collaboration and robust candidate evaluation.
Which statistical analysis capabilities are required before implementing cytokine readout comparisons?
Statistical analysis must support comparison of cytokine levels and immune cell counts across experimental groups, enabling detection of significant differences and supporting confident interpretation of immune modulation effects in preclinical research.
07:48
Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
Related Videos
0 Views
08:15
In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D
Related Videos
0 Views
06:57
Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Related Videos
0 Views
02:34
Intraperitoneal Injection of Bacterial Lipopolysaccharide in Mice to Study Systemic Immune Responses
Related Videos
0 Views
03:37
Intracisternal Delivery of Meningococci into Mouse Models to Induce Meningococcal Meningitis
Related Videos
0 Views
08:18
Evaluation of Vaccine-Induced Immunity Against Bacterial Infection in a Mouse Model
Related Videos
0 Views
02:49
A Technique to Assess the Immune Response against an Antigen by Inducing Skin Inflammation
Related Videos
0 Views
02:45
Induction of Experimental Autoimmune Encephalomyelitis in a Mouse Model
Related Videos
0 Views
02:27
Induction of Experimental Autoimmune Encephalomyelitis in a Mouse Model
Related Videos
0 Views
07:10
In vivo Imaging Method to Distinguish Acute and Chronic Inflammation
Related Videos
0 Views
Last updated: 18 July 2026